Long-Term, Prospective Performance of the MD Anderson Dysphagia Inventory in “Low-Intermediate Risk” Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy

International Journal of Radiation Oncology, Biology, Physics, Volume 97, Issue 4, 2017 Mar 15 | Goepfert, Ryan P., MD; Lewin, Jan S., PhD; Barrow, Martha P., MPH;...
Summary This study sought to characterize long-term * MD Anderson Dysphagia Inventory * results after primary IMRT and systemic therapy for oropharyngeal carcinoma among patients with "low-intermediate risk" disease. Most patients reported "optima...

http://ift.tt/2lDCwkw

http://ift.tt/2mg5bzg